Market closed
Xencor/$XNCR
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Xencor
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.
Ticker
$XNCR
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
280
Website
Xencor Metrics
BasicAdvanced
$1.6B
Market cap
-
P/E ratio
-$3.19
EPS
-
Beta
-
Dividend rate
Price and volume
Market cap
$1.6B
52-week high
$26.84
52-week low
$15.31
Average daily volume
377K
Financial strength
Current ratio
6.234
Quick ratio
6.015
Long term debt to equity
10.634
Total debt to equity
12.011
Interest coverage (TTM)
-79.50%
Management effectiveness
Return on assets (TTM)
-15.24%
Return on equity (TTM)
-29.02%
Valuation
Price to revenue (TTM)
16.908
Price to book
2.24
Price to tangible book (TTM)
2.3
Price to free cash flow (TTM)
55.258
Growth
Revenue change (TTM)
-41.37%
Earnings per share change (TTM)
60.72%
3-year revenue growth (CAGR)
-19.45%
3-year earnings per share growth (CAGR)
253.50%
What the Analysts think about Xencor
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Xencor stock.
Xencor Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Xencor Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Xencor News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Xencor stock?
Xencor (XNCR) has a market cap of $1.6B as of November 09, 2024.
What is the P/E ratio for Xencor stock?
The price to earnings (P/E) ratio for Xencor (XNCR) stock is 0 as of November 09, 2024.
Does Xencor stock pay dividends?
No, Xencor (XNCR) stock does not pay dividends to its shareholders as of November 09, 2024.
When is the next Xencor dividend payment date?
Xencor (XNCR) stock does not pay dividends to its shareholders.
What is the beta indicator for Xencor?
Xencor (XNCR) does not currently have a Beta indicator.